Immunotherapy Drugs Market Revenue 2024 to 2034
Immunotherapy Drugs Market Revenue 2024 to 2034
The immunotherapy drugs market will surge from USD 270.2 Bn in 2024 to USD 1,414.16 Bn by 2034, at an 18% CAGR, driven by CAR-T therapies, checkpoint inhibitors, and growing adoption of precision oncology solutions.
Report ID: 10655
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 270.20 Bn
Forecast Year,
USD 1,414.16 Bn
CAGR, 2025 -
18.00%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Immunotherapy Drugs Market Size Analysis
Immunotherapy Drugs Market Size By Drug Type 2024 to 2034 (USD )
| Drug Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Monoclonal Antibodies | 57.46 | 68.62 | 77.57 | 95.03 | 117.12 | 130.03 | 158.84 | 185.67 | 191.35 | 233.69 | 327.19 |
| Checkpoint Inhibitors | 10.11 | 12.28 | 15.96 | 16.42 | 18.86 | 35.58 | 14.74 | 28.68 | 70.67 | 79.08 | 41.66 |
| Cytokines | 83.54 | 97.95 | 116.56 | 137.23 | 163.37 | 182.23 | 214.04 | 267.78 | 331.92 | 343.60 | 444.97 |
| Cancer Vaccines | 42.39 | 49.68 | 59.29 | 70.92 | 78.04 | 103.14 | 134.05 | 143.12 | 131.90 | 172.97 | 216.66 |
| Others | 76.70 | 90.32 | 106.86 | 124.35 | 146.46 | 167.18 | 207.75 | 235.46 | 289.79 | 369.09 | 383.69 |
Immunotherapy Drugs Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 99.70 | 117.10 | 138.27 | 163.85 | 190.97 | 231.78 | 267.38 | 335.33 | 381.22 | 469.23 | 487.69 |
| Autoimmune Diseases | 108.38 | 128.57 | 151.90 | 178.13 | 209.70 | 243.83 | 285.98 | 327.42 | 381.47 | 483.47 | 568.91 |
| Infectious Diseases | 62.12 | 73.16 | 86.05 | 101.96 | 123.18 | 142.54 | 176.06 | 197.96 | 252.94 | 245.74 | 357.57 |
Immunotherapy Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 158.48 | 187.22 | 219.34 | 253.58 | 306.83 | 362.94 | 440.57 | 490.40 | 586.73 | 720.64 | 884.02 |
| Retail Pharmacies | 92.91 | 109.20 | 128.17 | 156.03 | 181.05 | 207.77 | 243.80 | 295.51 | 332.01 | 409.35 | 505.09 |
| Online Pharmacies | 18.81 | 22.41 | 28.71 | 34.34 | 35.98 | 47.44 | 45.04 | 74.79 | 96.89 | 68.46 | 25.05 |
Immunotherapy Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 73.39 | 87.68 | 101.50 | 120.91 | 144.35 | 162.91 | 198.40 | 244.49 | 267.52 | 309.83 | 375.86 |
| Europe | 26.75 | 31.15 | 36.36 | 36.33 | 52.53 | 60.83 | 82.74 | 102.75 | 112.62 | 76.40 | 113.46 |
| Asia Pacific | 78.30 | 92.29 | 109.75 | 132.45 | 151.26 | 179.56 | 204.24 | 234.78 | 277.12 | 380.31 | 422.17 |
| Latin America | 45.03 | 53.08 | 62.60 | 79.16 | 88.77 | 112.49 | 116.78 | 131.80 | 170.72 | 175.12 | 236.07 |
| Middle East & Africa | 46.73 | 54.63 | 66.02 | 75.09 | 86.94 | 102.35 | 127.26 | 146.89 | 187.65 | 256.78 | 266.59 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
